New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
09:15 EDTANR, IPCI, MIC, WLT, CGI, TXMD, NURO, TFM, GRPN, ABBV, SHPGOn The Fly: Pre-market Movers
HIGHER: Shire (SHPG), up 1% after AbbVie (ABBV) raises buyout offer for fourth time, to GBP 22.44 in cash and 0.8568 AbbVie shares per Shire share. AbbVie shares down about 1% in pre-market trading following the news... Groupon (GRPN), up 5.7% after upgraded at B. Riley... TherapeuticsMD (TXMD), up 21.8% after FBR Capital initiated the stock with an Outperform rating and $34 price target... NeuroMetrix (NURO), up 45% after wearable technology for treatment of chronic pain cleared by FDA... Celadon Group (CGI), up 7% after upgraded at Stifel... Macquarie Infrastructure (MIC), up 6.3% after acquiring remainder of IMTT for $1.025B in cash, stock. LOWER: Intellipharmaceutics (IPCI), down 10% after Q2 earnings lower than expected... The Fresh Market (TFM), down 6.6% after downgraded at Goldman... Walter Energy (WLT), down 4%, Alpha Natural (ANR), down 1%, after coal sector estimates lowered at Morgan Stanley.
News For SHPG;ABBV;GRPN;TFM;NURO;TXMD;CGI;WLT;MIC;IPCI;ANR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
October 14, 2014
10:51 EDTABBVGilead weakness a buying opportunity, says RBC Capital
Subscribe for More Information
10:05 EDTABBVAbbVie could cause Hep C price tipping point with aggressive pricing, WSJ says
Subscribe for More Information
October 13, 2014
09:23 EDTABBVAbbVie's Humira for hidradenitis suppurativa meets Phase 3 trial endpoint
AbbVie announced new results from PIONEER II, a pivotal Phase 3 study, demonstrating the effect of Humira in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa, specifically the number of abscesses and inflammatory nodules. The results of this study, in combination with previously presented results from PIONEER I, will contribute to worldwide regulatory filings for an expanded use of Humira, which is not currently approved by regulatory authorities for the treatment of HS.
07:39 EDTABBVPharmaceutical Care Management Association to hold annual meeting
Subscribe for More Information
07:37 EDTABBVAmerican Society of Anesthesiologists to hold annual meeting
Subscribe for More Information
07:13 EDTTXMDBioFlorida to hold a conference
Subscribe for More Information
October 10, 2014
10:01 EDTGRPNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:20 EDTMICMacquarie announces $116M performance fee payable to MIMUSA for Q3
Subscribe for More Information
09:00 EDTGRPNOn The Fly: Pre-market Movers
Subscribe for More Information
08:13 EDTGRPNGroupon downgraded to Sell from Equal Weight at Evercore
October 9, 2014
11:36 EDTWLT, ANRCoal price near-term rebound less likely after China tax, says Brean Capital
Subscribe for More Information
11:00 EDTWLT, ANRChina to reinstate tariffs on coal, Bloomberg reports
Subscribe for More Information
08:28 EDTABBVGilead to be challenged by AbbVie in HCV near-term, says Bernstein
Subscribe for More Information
05:45 EDTWLTStocks with implied volatility movement; WLT SHLD
Stocks with implied volatility movement; Walter Energy (WLT) 159, Sears (SHLD) 108 according to iVolatility.
05:22 EDTSHPGShire provides regulatory update on SHP 465
Subscribe for More Information
October 8, 2014
13:41 EDTTFMThe Fresh Market backs FY14 adjusted EPS view $1.56-$1.66, consensus $1.57
Subscribe for More Information
10:06 EDTCGIStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
10:00 EDTWLTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:08 EDTWLTWalter Energy downgraded at Morgan Stanley
Subscribe for More Information
07:18 EDTABBVInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use